Kolon Life Science’s ‘Invossa-K’ becomes game changer in osteoarthritis market

After being officially launched on 6 November, Kolon Life Science’s(CEO Woo-Seok Lee) ‘Invossa-K Inj’ has been settled as a new ‘game changer’ through various market activities, such as attracting foreign patients from the Korean osteoarthritis treatment market, taking more than 100^th procedures and landing in general hospitals.

According to the company, after the MOU to attract foreign patien...